Back to calendar
Amylyx Pharmaceuticals, Inc. (AMLX) Earnings
AMLX reports earnings on Thursday, November 5, 2026
earnings report
November 5, 2026 · Before Market Open
Q3 2026
Est. EPS: $-0.38
Actual EPS: $-0.39
EPS surprise: -8.06%
Company overview
Market Cap$4.2B
PriceUSD 33.75
EPS (TTM)-1.43
52-week high41.14
52-week low9.14
SectorHealth Technology
IndustryPharmaceuticals: Major
Employees136